BackgroundCheck.run
Search For

Mahesh D Desai, 712 Springdale Ct, Clifton, NJ 07013

Mahesh Desai Phones & Addresses

2 Springdale Ct, Clifton, NJ 07013    973-7795154   

6 Nash Ave, Clifton, NJ 07011    973-7722439   

2 Spring St, Clifton, NJ 07011   

Brooklyn, NY   

Passaic, NJ   

Work

Company: Center For Digestive Diseases Address: 120 Millburn Ave Suite M2, Millburn, NJ 07041 Phones: 973-4675900 (Phone)

Education

School / High School: Surat Municipal Institute Of Medical Education and Research, Veer Narmad South Gujarat University 1970

Languages

English

Ranks

Certificate: American Board of Internal Medicine Certification in Internal Medicine

Mentions for Mahesh D Desai

Career records & work history

Medicine Doctors

Mahesh Desai Photo 1

Dr. Mahesh R Desai, Millburn NJ - MD (Doctor of Medicine)

Specialties:
Gastroenterology
Address:
Center For Digestive Diseases
120 Millburn Ave Suite M2, Millburn, NJ 07041
973-4675900 (Phone)
Languages:
English
Hospitals:
Center For Digestive Diseases
120 Millburn Ave Suite M2, Millburn, NJ 07041
Saint Barnabas Medical Center
94 Old Short Hills Road, Livingston, NJ 07039
Newark Beth Israel Medical Center
201 Lyons Avenue, Newark, NJ 07112
Education:
Medical School
Surat Municipal Institute Of Medical Education and Research, Veer Narmad South Gujarat University
Graduated: 1970
Medical School
Northport Va Hospital
Graduated: 1974
Medical School
Northport Va Hospital
Graduated: 1975
Medical School
Albert Einstein Med Center
Graduated: 1977

Mahesh V. Desai

Specialties:
General Surgery
Work:
Atlanta Medical Center Wound Care Center
285 Blvd NE STE 145, Atlanta, GA 30312
404-2654325 (phone) 404-2654324 (fax)
Education:
Medical School
B J Med Coll, Gujarat Univ, Ahmedabad, Gujarat, India
Graduated: 1969
Procedures:
Laparoscopic Gallbladder Removal, Thyroid Gland Removal
Conditions:
Breast Disorders, Hemorrhoids, Inguinal Hernia, Rectal, Abdomen, Small Intestines, or Colon Cancer, Varicose Veins
Languages:
English
Description:
Dr. Desai graduated from the B J Med Coll, Gujarat Univ, Ahmedabad, Gujarat, India in 1969. He works in Atlanta, GA and specializes in General Surgery. Dr. Desai is affiliated with Southern Regional Medical Center and WellStar Atlanta Medical Center.
Mahesh Desai Photo 2

Mahesh Vasantlal Desai

Specialties:
General Practice
Surgery
Education:
B.J. Medical College (1969) Surgery
Mahesh Desai Photo 3

Mahesh R Desai, Millburn NJ

Specialties:
Gastroenterologist
Address:
120 Millburn Ave, Millburn, NJ 07041
Education:
Smt. N.H.L. Municipal Medical College - Doctor of Medicine
Albert Einstein Medical Center - Fellowship - Gastroenterology (Internal Medicine)
Northport VA Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)

Mahesh Desai resumes & CV records

Resumes

Mahesh Desai Photo 35

Mahesh Desai - Livingston, NJ

Work:
PSEG Power - Newark, NJ Mar 2008 to Dec 2010
contract employee
Shaw Stone & Webster - Trenton, NJ Apr 2006 to Jan 2008
Structural Engineer
Washington Group International - Princeton, NJ Mar 2006 to Dec 2006 PSEG Power - Newark, NJ Apr 2002 to Jun 2005 PSEG Power - Newark, NJ Jul 1989 to Apr 2002
Lead Designer
ACI, AISC, AASHTO, and OSHA 2000 to 2000
Construction Staff Engineer
PSE&G - Newark, NJ Jul 1984 to Jun 1989
Designer
PSE&G - Newark, NJ Jul 1981 to Jun 1984
Associate Designer
PSE&G - Newark, NJ Aug 1979 to Jul 1981
Designer
Foster Wheeler Corporation - Livingston, NJ Mar 1979 to Aug 1979
Structural Designer
Lummus Company - Bloomfield, NJ Mar 1977 to Mar 1979
Structural Designer
Louis Berger & Associates - East Orange, NJ Nov 1974 to Mar 1977
Structural Engineer
Ray Consulting, Inc - Highland Park, NJ Mar 1974 to Nov 1974
Designer
Branchburg Truss & Component Company - Somerville, NJ Mar 1973 to Mar 1974
Draftsman/Estimator
Education:
Institute of New York University - Brooklyn, NY 1982
Master of Science in Structural Engineering
Lukhndhirjee Engineering College
Bachelor of Engineering in Civil Engineering

Publications & IP owners

Us Patents

Selective Npy (Y5) Antagonists (Triazines)

US Patent:
6340683, Jan 22, 2002
Filed:
Apr 22, 1999
Appl. No.:
09/296332
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ
Stewart A. Noble - Upper Saddle River NJ
Mahesh N. Desai - Clifton NJ
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
C07D25150
US Classification:
514245, 544197, 544198, 544208, 544209
Abstract:
This invention is directed to triazine derivatives which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

Selective Npy (Y5) Antagonists (Triazines)

US Patent:
6569856, May 27, 2003
Filed:
Jan 3, 2002
Appl. No.:
10/037859
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ
Stewart A. Noble - Upper Saddle River NJ
Mahesh N. Desai - Clifton NJ
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
C07D25150
US Classification:
514245, 544197, 544198, 544208, 544209
Abstract:
This invention is directed to triazine derivatives which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

Selective Npy (Y5) Antagonists

US Patent:
7189720, Mar 13, 2007
Filed:
Apr 6, 2005
Appl. No.:
11/099960
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
Stewart A. Noble - San Diego CA, US
Mahesh N. Desai - Nutley NJ, US
Assignee:
H. Lundbeck A/S - Valby-Copenhagen
International Classification:
C07D 251/50
C07D 251/70
A61K 31/53
A61P 3/04
US Classification:
514245, 544197, 544198, 544208, 544209
Abstract:
This invention is directed to triazine derivatives, bicyclic compounds and tricyclic compounds which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. This invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.

Selective Npy (Y5) Antagonists (Triazines)

US Patent:
2004001, Jan 29, 2004
Filed:
Apr 22, 2003
Appl. No.:
10/420238
Inventors:
Mohammad Marzabadi - Ridgewood NJ, US
Stewart Nobel - Upper Saddle River NJ, US
Mahesh Desai - Clifton NJ, US
Assignee:
Synaptic Pharmaceutical Corporation
International Classification:
A61K031/53
C07D251/18
C07D251/48
C 07D 4 3/02
US Classification:
514/245000, 544/204000, 544/209000
Abstract:
This invention is directed to triazine derivatives which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

Selective Npy (Y5) Antagonists

US Patent:
2008004, Feb 21, 2008
Filed:
Mar 12, 2007
Appl. No.:
11/716925
Inventors:
Mohammad Marzabadi - Ridgewood NJ, US
Wai Wong - Hamden CT, US
Stewart Noble - San Diego CA, US
Mahesh Desai - Nutley NJ, US
Assignee:
H. Lundbeck A/S - Valby-Copenhagen
International Classification:
A61K 31/53
A61K 31/426
A61K 31/5377
C07D 251/54
C07D 413/12
C07D 417/04
C07D 413/14
C07D 277/38
A61P 3/00
A61K 31/4436
US Classification:
514232200, 514236200, 514245000, 514342000, 514366000, 514370000, 544113000, 544197000, 544198000, 544083000, 546270400, 548151000, 548198000
Abstract:
This invention is directed to triazine derivatives, bicyclic compounds and tricyclic compounds which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. This invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.

Dry Stabilized Microemulsified Omega-Three Acid-Containing Oils

US Patent:
4867986, Sep 19, 1989
Filed:
Jul 17, 1987
Appl. No.:
7/074935
Inventors:
Mahesh Desai - Hawthorne NJ
Frank Molinaro - West Orange NJ
Assignee:
Pharmachem Laboratories, Inc. - South Hackensack NJ
International Classification:
A61K 920
US Classification:
424464
Abstract:
Storage-stable, bio-available, free-flowing, microemulsified, Omega-three acid-containing oil compositions in the form of microspheres and macrospheres, said compositions consisting essentially of (1) up to about 70% by weight of Omega-three acid-containing oil, and (2) gelatin, in which the oil is microemulsified by the gelatin; processes for their preparation; and product applications (including tablet-type solid forms, dry powders, and spoonable, drinkable emulsions).

Isbn (Books And Publications)

The Journey, And Other Poems

Author:
Mahesh Desai
ISBN #:
0720500214

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.